Danaher (DHR) to Announce Quarterly Earnings on Tuesday

Danaher (NYSE:DHR) is projected to post its Q2 2026 results before the market opens on Tuesday, July 21st. Analysts expect Danaher to announce earnings of $1.83 per share and revenue of $6.0975 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Tuesday, July 21, 2026 at 8:00 AM ET.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the firm posted $1.88 earnings per share. The company’s quarterly revenue was up 3.7% on a year-over-year basis. On average, analysts expect Danaher to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Danaher Price Performance

Shares of NYSE:DHR opened at $200.45 on Tuesday. The business has a fifty day moving average price of $181.02 and a 200-day moving average price of $199.06. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The company has a market capitalization of $141.87 billion, a PE ratio of 38.77, a PEG ratio of 2.54 and a beta of 0.79. Danaher has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Hedge Funds Weigh In On Danaher

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Viking Global Investors LP boosted its holdings in shares of Danaher by 543.9% during the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after acquiring an additional 2,455,994 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of Danaher by 11.2% in the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after acquiring an additional 1,517,904 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Danaher by 9.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after acquiring an additional 1,334,221 shares during the period. Generation Investment Management LLP raised its holdings in shares of Danaher by 14.1% during the fourth quarter. Generation Investment Management LLP now owns 7,589,661 shares of the conglomerate’s stock valued at $1,737,425,000 after purchasing an additional 934,995 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in shares of Danaher by 23.7% during the third quarter. Invesco Ltd. now owns 3,813,128 shares of the conglomerate’s stock valued at $755,991,000 after purchasing an additional 729,597 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Royal Bank Of Canada started coverage on shares of Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 price objective for the company. Evercore reiterated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Morgan Stanley reduced their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Finally, Piper Sandler started coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $231.64.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.